| [1] |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3):229-263. doi: 10.3322/caac.21834.
|
| [2] |
Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040[J]. J Hepatol, 2022, 77(6):1598-1606. doi: 10.1016/j.jhep.2022.08.021.
pmid: 36208844
|
| [3] |
Singal AG, Llovet JM, Yarchoan M, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma[J]. Hepatology, 2023, 78(6):1922-1965. doi: 10.1097/HEP.0000000000000466.
pmid: 37199193
|
| [4] |
Vogel A, Chan SL, Dawson LA, et al. Hepatocellular carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up[J]. Ann Oncol, 2025, 36(5):491-506. doi: 10.1016/j.annonc.2025.02.006.
pmid: 39986353
|
| [5] |
Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update[J]. J Hepatol, 2022, 76(3):681-693. doi: 10.1016/j.jhep.2021.11.018.
|
| [6] |
|
| [7] |
Shinkawa H, Tanaka S, Kabata D, et al. The prognostic impact of tumor differentiation on recurrence and survival after resection of hepatocellular carcinoma is dependent on tumor size[J]. Liver Cancer, 2021, 10(5):461-472. doi: 10.1159/000517992.
pmid: 34721508
|
| [8] |
International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia[J]. Hepatology, 2009, 49(2):658-664. doi: 10.1002/hep.22709.
pmid: 19177576
|
| [9] |
Huang Y, Chen L, Ding Q, et al. CT-based radiomics for predicting pathological grade in hepatocellular carcinoma[J]. Front Oncol, 2024, 14:1295575. doi: 10.3389/fonc.2024.1295575.
|
| [10] |
Chen W, Zhang T, Xu L, et al. Radiomics analysis of contrast-enhanced CT for hepatocellular carcinoma grading[J]. Front Oncol, 2021, 11:660509. doi: 10.3389/fonc.2021.660509.
|
| [11] |
Tong X, Li J. Noninvasively predict the micro-vascular invasion and histopathological grade of hepatocellular carcinoma with CT-derived radiomics[J]. Eur J Radiol Open, 2022, 9:100424. doi: 10.1016/j.ejro.2022.100424.
|
| [12] |
Li XM, Nguyen T, Sparks HD, et al. Quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in hepatocellular carcinoma: A review of emerging applications for locoregional therapy[J]. Bioengineering (Basel), 2025, 12(8):870. doi: 10.3390/bioengineering12080870.
|
| [13] |
Mao Y, Wang J, Zhu Y, et al. Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma[J]. Hepatobiliary Surg Nutr, 2022, 11(1):13-24. doi: 10.21037/hbsn-19-870.
|
| [14] |
Hu X, Li C, Wang Q, et al. Development and external validation of a radiomics model derived from preoperative gadoxetic acid-enhanced MRI for predicting histopathologic grade of hepatocellular carcinoma[J]. Diagnostics (Basel), 2023, 13(3):413. doi: 10.3390/diagnostics13030413.
|
| [15] |
Yang D, She H, Wang X, et al. Diagnostic accuracy of quantitative diffusion parameters in the pathological grading of hepatocellular carcinoma: A meta-analysis[J]. J Magn Reson Imaging, 2020, 51(5):1581-1593. doi: 10.1002/jmri.26963.
pmid: 31654537
|
| [16] |
Xu YS, Liu HF, Xi DL, et al. Whole-lesion histogram analysis metrics of the apparent diffusion coefficient: A correlation study with histological grade of hepatocellular carcinoma[J]. Abdom Radiol (NY), 2019, 44(9):3089-3098. doi: 10.1007/s00261-019-02109-w.
|
| [17] |
Zhou Y, Yang G, Gong XQ, et al. A study of the correlations between IVIM-DWI parameters and histologic differentiation of hepatocellular carcinoma[J]. Sci Rep, 2021, 11(1):10392. doi: 10.1038/s41598-021-89784-2.
pmid: 34001962
|
| [18] |
Yang CC, Wei XQ, Zheng J, et al. A correlative study between IVIM-DWI parameters and VEGF and MMPs expression in hepatocellular carcinoma[J]. Quant Imaging Med Surg, 2023, 13(3):1887-1898. doi: 10.21037/qims-22-271.
|
| [19] |
Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: Extracting more information from medical images using advanced feature analysis[J]. Eur J Cancer, 2012, 48(4):441-446. doi: 10.1016/j.ejca.2011.11.036.
pmid: 22257792
|
| [20] |
Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data[J]. Radiology, 2016, 278(2):563-577. doi: 10.1148/radiol.2015151169.
pmid: 26579733
|
| [21] |
van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype[J]. Cancer Res, 2017, 77(21):e104-e107. doi: 10.1158/0008-5472.CAN-17-0339.
|
| [22] |
Zwanenburg A, Vallieres M, Abdalah MA, et al. The Image Biomarker Standardisation Initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping[J]. Radiology, 2020, 295(2):328-338. doi: 10.1148/radiol.2020191145.
pmid: 32154773
|
| [23] |
Collins GS, Moons KGM, van Smeden M, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods[J]. BMJ, 2024, 385:e078378. doi: 10.1136/bmj-2023-078378.
|
| [24] |
Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: The bridge between medical imaging and personalized medicine[J]. Nat Rev Clin Oncol, 2017, 14(12):749-762. doi: 10.1038/nrclinonc.2017.141.
pmid: 28975929
|
| [25] |
Lambin P, Woodruff HC, Mali SA, et al. Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine[J]. Nat Rev Clin Oncol, 2025, 22(11):831-846. doi: 10.1038/s41571-025-01067-1.
|
| [26] |
Orlhac F, Frouin F, Nioche C, et al. Validation of a method to compensate multicenter effects affecting CT radiomics[J]. Radiology, 2019, 291(1):53-59. doi: 10.1148/radiol.2019182023.
pmid: 30694160
|
| [27] |
Liu HF, Wang M, Wang Q, et al. Multiparametric MRI-based intratumoral and peritumoral radiomics for predicting the pathological differentiation of hepatocellular carcinoma[J]. Insights Imaging, 2024, 15(1):97. doi: 10.1186/s13244-024-01623-w.
|
| [28] |
Han YE, Cho Y, Kim MJ, et al. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: A two-center study[J]. Abdom Radiol (NY), 2023, 48(1):244-256. doi: 10.1007/s00261-022-03679-y.
|
| [29] |
Ameli S, Venkatesh BA, Shaghaghi M, et al. Role of MRI-derived radiomics features in determining degree of tumor differentiation of hepatocellular carcinoma[J]. Diagnostics (Basel), 2022, 12(10):2386. doi: 10.3390/diagnostics12102386.
|
| [30] |
Geng Z, Zhang Y, Wang S, et al. Radiomics analysis of susceptibility weighted imaging for hepatocellular carcinoma: Exploring the correlation between histopathology and radiomics features[J]. Magn Reson Med Sci, 2021, 20(3):253-263. doi: 10.2463/mrms.mp.2020-0060.
|
| [31] |
Wei J, Ji Q, Gao Y, et al. A multi-scale, multi-region and attention mechanism-based deep learning framework for prediction of grading in hepatocellular carcinoma[J]. Med Phys, 2023, 50(4):2290-2302. doi: 10.1002/mp.16127.
|
| [32] |
Wang Q, Liu Q, Xu X, et al. Preoperative CT-and MRI-based radiomics for predicting histopathologic grade of hepatocellular carcinoma: A systematic review and radiomics quality score assessment[J]. Eur J Radiol, 2023, 164:110838. doi: 10.1016/j.ejrad.2023.110838.
|
